When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Rituximab - Wikipedia

   en.wikipedia.org/wiki/Rituximab

   Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...

3. Immune thrombocytopenic purpura - Wikipedia

   en.wikipedia.org/.../Immune_thrombocytopenic_purpura

   Thrombopoietin receptor agonists exhibited the greatest success so far in treating patients with refractory ITP. [37] Side effects of thrombopoietin receptor agonists include headache, joint or muscle pain, dizziness, nausea or vomiting, and an increased risk of blood clots. [31]

4. Fostamatinib - Wikipedia

   en.wikipedia.org/wiki/Fostamatinib

   Rigel reported results from two Phase III clinical trials for fostamatinib as an ITP treatment in August and October 2016. The study is the second Phase 3, multi-center, randomized, double-blind, placebo controlled, study of fostamatinib disodium in the treatment of persistent/chronic immune thrombocytopenic purpura that Rigel has conducted.

5. The 'Carter effect': How the former president gave cancer ...

   www.aol.com/carter-effect-former-president-gave...

   There can be side effects. Immunotherapy can kick the immune system into overdrive, causing a variety of inflammatory responses. People who develop lung inflammation may need supplemental oxygen.

6. CHOP (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/CHOP_(chemotherapy)

   This regimen can also be combined with the monoclonal antibody rituximab if the lymphoma is of B cell origin; this combination is called R-CHOP. In 2002, a randomized controlled trial showed a higher complete response rate for R-CHOP vs CHOP in elderly patients with Diffuse Large-B-Cell Lymphoma (76% vs 63%). [ 4 ]

7. Statin-associated autoimmune myopathy - Wikipedia

   en.wikipedia.org/wiki/Statin-associated...

   Rituximab or intravenous immunoglobulin are recommended as add-on therapy in such cases. [3] Intravenous immunoglobulin is an appropriate first-line therapy in select individuals. Suitable candidates for first-line intravenous immunoglobulin include people who have diabetes mellitus or who wish to avoid corticosteroid therapy.